Announcements Trials

Browse Landscape

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × mCRC × 1 year × Clear all

Phase

Phase 2 1 Phase 1 1

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 377 Neoplasms 323 Neoplasm Metastasis 286 Leukemia, Myeloid, Acute 283 Breast Neoplasms 280 Colorectal Neoplasms 234 Melanoma 201 Ovarian Neoplasms 196 Recurrence 191 Multiple Myeloma 178 Lung Neoplasms 159 Prostatic Neoplasms 155 Pancreatic Neoplasms 155 Squamous Cell Carcinoma of Head and Neck 149 Glioblastoma 147 Lymphoma, Non-Hodgkin 146 Triple Negative Breast Neoplasms 122 Myelodysplastic Syndromes 116 Carcinoma, Renal Cell 114 Glioma 111 Brain Neoplasms 109 Stomach Neoplasms 108 Advanced Solid Tumors 105 Lymphoma, Large B-Cell, Diffuse 104 Lymphoma, B-Cell 104 Lymphoma 104 Precursor Cell Lymphoblastic Leukemia-Lymphoma 99 Endometrial Neoplasms 97 Carcinoma, Hepatocellular 95 Leukemia, Lymphocytic, Chronic, B-Cell 91

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07543471 2026-04-21

PK equivalence

Shanghai Henlius Biotech

Phase 1 Not yet recruiting

mCRC

Data powered by HemOnc (CC BY 4.0) Colophon ⚡